CLEAN, SAFE, & TRANSPARENT FORMULA: No artificial sweeteners, flavors, dyes, or fillers
Research has investigated TB-500s potential for cardiac repair following heart attack, with studies examining its ability to promote the formation of new blood vessels and improve cardiac function
GLP-1 weight loss treatments have changed the way many people manage their weight
The Three Primary Injection Sites Clinical trials for branded medications like Mounjaro and Zepboundwhich contain the active ingredient tirzepatidehave identified three primary areas for subcutaneous administration
Clinical trials show blood pressure improvements begin within weeks of starting GLP-1 therapy, even before significant weight reduction occurs
Persistent vomiting or diarrhoea can lead to dehydration, which in turn may increase the risk of acute kidney injury a class-relevant concern also noted in the Summary of Product Characteristics (SmPC) for approved GLP-1 receptor agonists such as semaglutide